Grant: Engage Grants Program
University of Ottawa
$25,000.00
The use of aptamers to measure serum thyroglobulin in the presence of autoantibodies
FY 2012-13
Summary
This engage project targets the development of aptamers detecting thyroglobulin (Tg) and its complex with autoantibodies (TgAb) in human blood serum. Thus, TgAb interference is undoubtedly the most serious technical problem that currently limits the utility of serum Tg measurement in the management of well-differentiated thyroid carcinoma (WDTC), a disease causing 33,000 new cases every year in Canada and USA. Together with an industrial partner - Proteocyte Diagnostics Inc, we plan to make an aptasensor recognizing free and antibody-bound forms of Tg. The final mission of the project will be a robust protocol for the development of aptamers for the rapid quantitation of the total amount of Tg in the presence of autoantibodies. If aptamers will distinguish this difference between normal and cancerous Tg levels, this will obviously be of commercial potential and would be integrated into Proteocyte's program to develop a thyroid carcinoma test. The aptamer technology will help the company launch new disease-specific molecular diagnostics for the research and the clinical market. We anticipate that during the course of the engage project new scientific collaboration will be established what opens doors for future mutual projects.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
436520-2012
Name nom
Berezovski, Maxim
Department département
Chemistry
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
The use of aptamers to measure serum thyroglobulin in the presence of autoantibodies
Keyword
NSERC
Application summary
This engage project targets the development of aptamers detecting thyroglobulin (Tg) and its complex with autoantibodies (TgAb) in human blood serum. Thus, TgAb interference is undoubtedly the most serious technical problem that currently limits the utility of serum Tg measurement in the management of well-differentiated thyroid carcinoma (WDTC), a disease causing 33,000 new cases every year in Canada and USA. Together with an industrial partner - Proteocyte Diagnostics Inc, we plan to make an aptasensor recognizing free and antibody-bound forms of Tg. The final mission of the project will be a robust protocol for the development of aptamers for the rapid quantitation of the total amount of Tg in the presence of autoantibodies. If aptamers will distinguish this difference between normal and cancerous Tg levels, this will obviously be of commercial potential and would be integrated into Proteocyte's program to develop a thyroid carcinoma test. The aptamer technology will help the company launch new disease-specific molecular diagnostics for the research and the clinical market. We anticipate that during the course of the engage project new scientific collaboration will be established what opens doors for future mutual projects.